We conducted a systematic analysis of the literature to evaluate the impact of non-insulin glucose-lowering drugs on weight loss in patients with type 2 diabetes
The peptide improved healing in diabetic and ischemic wound models, and systemic wound healing was demonstrated across rats, mice, and pigs (Pickart & Margolina, 2018)
A retatrutide launch into uncovered demand would create the same conditions
Mounjaro is listed as a preferred drug in the Aetna Standard Plan and Aetna Advanced Control Plan for 2025, meaning it is more likely to be covered by Aetna than nonpreferred drugs
This should raise alarms The staggeringly high discontinuation rates of GLP-1 RA should raise alarms for clinicians, policy makers, and public health experts, said Khan, associate professor of medicine (cardiology) and preventive medicine (epidemiology) at Northwestern University Feinberg School of Medicine and a Northwestern Medicine physician